Novartis' Jakavi turns out positive PhIII results in PV; 'Are you prepared for anaphylaxis?' Adrian Peterson asks;

> Phase III data show polycythemia vera patients on Novartis' ($NVS) Jakavi achieved significant improvement in disease control. Release

> Johnson & Johnson ($JNJ) has shifted its U.S. media buying account to OMD, part of the Omnicom Media Group division of the Omnicom Group. More (sub. req.)

> AbbVie ($ABBV), Astellas and Roche ($RHHBY) have been nominated for the Pegasus Award for In-House Team of the Year at Communiqué. More

> Brand experience agency SSG Create has secured Botox-maker Allergan ($AGN) as a client. Report

> IDEA Pharma has appointed UPenn research specialist Rick Ritacco to its New York practice. Release

> Jack Morton Worldwide has opened an office in Düsseldorf, Germany, following client wins with Novartis ($NVS) and Merck Serono. More

> Johnson & Johnson ($JNJ), a World Cup sponsor through its Listerine and Regaine brands, has helped fuel growth at sponsorship agency Prism. More

And Finally... EpiPen maker Mylan ($MYL) and NFL star Adrian Peterson are calling on Americans to learn to be aware and prepared for anaphylaxis. Release

Suggested Articles

In a head-to-head against Bayer's Nexavar, Opdivo failed to significantly extend patients' lives in newly diagnosed liver cancer patients.

Lions Health shared what worked, what campaigns they wish they had created and what they’ll take back home to talk about with their colleagues.

AMAG's female libido drug Vyleesi has just won FDA approval. But will it reach blockbuster state? Management and analysts have different opinions.